Everything you need to know about TMS for Binge Eating Disorder: Targeting the Compulsive Eating Brain — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Binge eating disorder (BED) is the most common eating disorder in the United States, affecting approximately 2.8% of adults at some point in their lives — more than twice the prevalence of anorexia nervosa and bulimia nervosa combined. Characterized by recurrent episodes of eating large quantities of food in a discrete period, accompanied by a sense of loss of control and significant distress, BED is strongly associated with obesity, depression, anxiety, and metabolic syndrome. Despite its prevalence and health consequences, BED remains underdiagnosed and undertreated, with many patients failing to achieve adequate relief from available treatments. Transcranial magnetic stimulation is emerging as a promising intervention that targets the neurobiological circuits underlying binge eating and food addiction.

What You’ll Learn

• How the dopaminergic reward system, orbitofrontal cortex, and DLPFC are dysregulated in BED
• Why the insula and prefrontal regulatory failure drive compulsive eating behaviors
• What research shows about TMS for reducing binge eating episodes and cravings
• How Deep TMS compares to standard TMS for BED
• How TMS compares to existing treatments like CBT and lisdexamfetamine

Understanding Binge Eating Disorder: A Brain-Based Disorder

Research over the past two decades has established that binge eating is not simply a matter of poor willpower or emotional dysregulation — it is accompanied by measurable abnormalities in brain structure and function, particularly in circuits governing reward, impulsivity, and executive control.

The dopaminergic reward system plays a central role in BED. Neuroimaging studies consistently show that individuals with BED have altered dopamine receptor availability in the striatum (including the nucleus accumbens), similar to patterns observed in substance use disorders. When binge eaters consume highly palatable foods — those rich in sugar, fat, and salt — their reward circuits respond with greater activation than in non-binge eaters, suggesting a neurobiological basis for the excessive consumption.

The orbitofrontal cortex (OFC) — which encodes the subjective value of rewards and helps regulate eating behavior based on expected consequences — shows reduced activity and altered connectivity in BED. This dysfunction may explain why binge eaters continue to eat despite knowing the negative consequences of their behavior.

The dorsolateral prefrontal cortex (dlPFC) — responsible for executive function, impulse control, and decision-making — is often underactive in BED patients. This prefrontal impairment likely contributes to the loss of control during binge episodes: the brain’s regulatory systems fail to inhibit the compulsive drive to eat.

The insula — involved in interoceptive awareness (including hunger and satiety signals) and in craving — is hyperactive in BED, particularly in response to images of highly palatable food. This heightened insula response may drive food cravings that become irresistible in certain contexts.

Together, these findings paint a picture of BED as a disorder of reward-circuit hyperreactivity combined with prefrontal regulatory failure — a pattern strikingly similar to what is observed in substance use disorders.

How TMS Targets Binge Eating

TMS for BED typically targets the dorsolateral prefrontal cortex (dlPFC) and the orbitofrontal cortex (OFC), with the goal of:

1. Enhancing prefrontal regulatory function to improve impulse control during binge episodes
2. Modulating reward-circuit hyperactivity to reduce the reinforcing value of binge eating
3. Reducing craving-related activity in the insula and OFC

High-frequency (excitatory) TMS to the left dlPFC is most commonly used, based on evidence from depression research suggesting that this approach enhances prefrontal executive function. The rationale is that strengthening dlPFC activity will restore top-down control over the reward-driven urge to binge.

Low-frequency (inhibitory) TMS to the right dlPFC or OFC has also been explored, targeting the right hemisphere’s role in reward and avoidance systems. Some researchers hypothesize that reducing right-sided reward processing may diminish the hedonic drive to binge.

Deep TMS using the H-coil has been studied specifically for BED, because H-coils can reach deeper structures including the OFC and insula that are difficult or impossible to stimulate with standard coils.

What the Research Shows

The evidence for TMS in BED is promising but still in early stages:

A 2015 proof-of-concept study published in Brain Stimulation found that a single session of high-frequency TMS to the left dlPFC significantly reduced cravings for highly palatable foods in binge eating disorder patients. Participants who received active TMS reported less desire to eat high-calorie foods and were able to resist consumption in a subsequent taste-test paradigm compared to the sham group.

A more rigorous randomized controlled trial published in Translational Psychiatry enrolled patients with BED and randomized them to receive 20 sessions of high-frequency left dlPFC TMS or sham treatment over four weeks. The results showed:

• Significantly greater reduction in binge eating episodes in the active TMS group
• Greater reduction in body weight in the active TMS group
• Reduced cravings for high-fat and high-sugar foods, as measured by food cue reactivity paradigms
• Improved executive function scores on cognitive testing

A 2022 study specifically examining deep TMS for BED found that the H-coil protocol targeting bilateral prefrontal regions produced even larger reductions in binge frequency than standard TMS, with approximately 40% of patients achieving abstinence from binge episodes during the final two weeks of treatment.

Importantly, neuroimaging conducted before and after TMS treatment has shown that successful treatment is associated with reduced activation in the OFC and insula in response to food cues — the same hyperactive reward regions that characterize BED. This suggests that TMS works by normalizing the underlying brain dysfunction rather than merely suppressing symptoms.

TMS vs. Existing BED Treatments

The first-line treatments for BED are cognitive-behavioral therapy (CBT) and lisdexamfetamine (Vyvanse), the latter of which is FDA-approved specifically for BED. Both have demonstrated efficacy, but neither is effective for all patients:

• CBT produces response rates of approximately 40-50%, but access to qualified therapists is limited and treatment dropout rates are high
• Lisdexamfetamine is effective for many patients but carries risks of cardiovascular side effects, dependence, and psychiatric symptoms
• SSRIs, while sometimes used off-label, have limited evidence specifically for BED

TMS offers a non-pharmacological, non-psychotherapy alternative that directly targets the brain circuits implicated in BED. It does not interact with medications, does not carry the dependence risk of stimulants, and does not require the intensive time commitment of CBT. This makes it a potentially valuable option for patients who have not responded to or cannot tolerate existing treatments.

A Promising but Emerging Field

It is important to note that TMS for BED is not yet FDA-cleared for this indication. The evidence base, while growing, still consists of relatively small trials, and definitive clinical guidelines have not been established.

Nevertheless, the convergence of compelling neuroimaging evidence, promising pilot trial results, and the known mechanisms of TMS in related disorders (depression, OCD, addiction) makes BED a highly promising area for TMS research.

For patients struggling with binge eating disorder who have found existing treatments insufficient, TMS — available off-label from experienced neuromodulation practitioners — represents a scientifically grounded option that addresses the neurological roots of compulsive eating.